Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Visbiome for Inflammation in HIV II
NCT02441231Phase 2Unknown
- Sponsor
- University Health Network
- Start
- Nov 2015
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by University Health Network. Primary endpoint: Percent change in blood immune activation at 48 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT02441231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02441231.